Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Zepbound (tirzepatide) supports significant blood sugar control and weight loss, but some users experience temporary hair thinning. This shedding is typically linked to rapid weight loss, nutrient deficiencies, and physiological stress—not the medication directly damaging hair follicles.
Whether to switch medications depends on shedding severity and how well underlying factors like protein intake, iron, zinc, and biotin levels are managed. Key strategies include monitoring hair loss patterns, optimizing nutrition, practicing gentle hair care, and consulting your healthcare provider before making changes.
Because hair thinning can also signal thyroid issues, hormonal imbalances, or other health conditions unrelated to Zepbound, it's important to rule out other causes. A free, instant, online symptom check can help you evaluate your specific symptoms in minutes, identify potential underlying conditions, and clarify your next steps—so you can have a more informed conversation with your provider before adjusting your treatment.
Reviewed for medical accuracy: 07/10/2026
Zepbound (tirzepatide) is a breakthrough medication approved for type 2 diabetes and weight management. While many patients experience dramatic improvements in blood sugar control and significant weight loss, some report an unexpected side effect: hair thinning or shedding. If you've noticed more hairs on your brush or pillow, you're not alone. Understanding why Zepbound causes hair loss, how common it is, and what you can do about it will help you decide whether to stick with your current regimen or consider alternatives.
Zepbound combines two hormone-mimicking actions:
Together, these effects lead to better glycemic control and weight reduction—key goals for many patients with metabolic conditions.
Hair growth occurs in cycles:
When more hairs shift prematurely into telogen, you'll notice increased shedding. This phenomenon—known as telogen effluvium—can be triggered by stressors such as rapid weight loss, nutritional changes, illness, or medications.
Although clinical trials for tirzepatide did not list hair loss as a common side effect, real-world reports suggest several plausible mechanisms:
Rapid Weight Loss
Nutrient Deficiencies
Metabolic and Hormonal Shifts
Stress on the Body
Deciding whether to stop Zepbound depends on weighing benefits against the impact of hair loss on your quality of life:
Benefits of Staying on Zepbound
Consider Switching If
Always discuss these factors with your healthcare provider before making any changes.
If you choose to continue Zepbound, you can take steps to support healthy hair growth:
Nutrition
Gentle Hair Care
Stress Management
Medical Treatments
Track your hair shedding and associated symptoms:
If you experience any of the following, speak to a healthcare professional promptly:
Experiencing unusual symptoms alongside hair loss and not sure what's causing them? Use Ubie's free AI-powered symptom checker to evaluate all your symptoms together and receive personalized guidance on whether you should schedule a routine checkup or seek more immediate care.
Hair loss while on Zepbound can be distressing, but it's often a temporary adjustment as your body adapts to rapid metabolic changes. Before deciding to switch medications, weigh the metabolic benefits against the severity of hair shedding. Many patients find that nutritional support, gentle hair care, and time help normalize growth cycles.
If hair loss persists beyond six months or worsens despite lifestyle measures, consult your healthcare provider for a personalized evaluation. And remember: only a qualified medical professional can diagnose and recommend treatment for conditions that could be serious or life-threatening. Always speak to a doctor before making any changes to your medication regimen.
(References)
* Yu J, Wang X, Wu Z, He S, Li D, Yu Z. Adverse Events Associated with Tirzepatide for Weight Loss in Adults: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2024 Jan 18;109(2):e53-e66. doi: 10.1210/clinem/dgad596. PMID: 37782167.
* Tang C, Huang G, Luo P, Pan Y. Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis. J Clin Pharmacol. 2023 Dec;63(12):1426-1437. doi: 10.1002/jcph.2346. Epub 2023 Jun 23. PMID: 37353907.
* El-Fouly AA, Al-Hashel MA, El-Fouly AA, Al-Ajami A. Hair loss in obesity and after bariatric surgery: a systematic review. Obes Surg. 2023 Dec;33(12):3731-3738. doi: 10.1007/s11695-023-06835-2. Epub 2023 Sep 15. PMID: 37714856.
* Al-Fahoum M, Khawaja M, Sary K, Al-Bustami D. Tirzepatide for the treatment of obesity: a narrative review. J Basic Clin Physiol Pharmacol. 2024 Jan 17;35(1):79-87. doi: 10.1515/jbcpp-2023-0255. PMID: 38237243.
* Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The Role of Vitamins and Minerals in Hair Loss: A Review. Dermatol Ther (Heidelb). 2019 Sep;9(3):51-70. doi: 10.1007/s13555-018-0278-6. Epub 2018 Dec 13. PMID: 30546945.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.